237 related articles for article (PubMed ID: 5087111)
1. The natural history of hepatitis-associated (Australia)-antigen (HAA)-positive chronic liver disease.
Dudley FJ; Scheuer PJ; Sherlock S
Gut; 1972 Oct; 13(10):852. PubMed ID: 5087111
[No Abstract] [Full Text] [Related]
2. [Hepatitis and cirrhosis].
Thaler H
Dtsch Med Wochenschr; 1975 May; 100(18):1018-25. PubMed ID: 1132319
[No Abstract] [Full Text] [Related]
3. [Treatment of chronic diseases of the liver].
Loginov AS
Ter Arkh; 1977; 49(1):3-9. PubMed ID: 867234
[No Abstract] [Full Text] [Related]
4. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis].
Bakulenko EF
Vrach Delo; 1976 Apr; (4):108-10. PubMed ID: 1007172
[No Abstract] [Full Text] [Related]
5. [Interpretation possibilities of the presence of Australia antigen (Au. an.) in patients with chronic hepatitis and hepatic cirrhosis].
Turcu E; Efanov A; Macarie C
Med Interna (Bucur); 1973 Sep; 25(9):1127-34. PubMed ID: 4209305
[No Abstract] [Full Text] [Related]
6. Australia antigen and liver diseases. Report on personal cases and review of the literature.
Frosini G; Lombardini L; Marchi B; Toti M; Alegente G; Pippi L
Quad Sclavo Diagn; 1975 Dec; 11(4):770-85. PubMed ID: 1232643
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenetic aspects of immunoglobulins of HAA positive and HAA negative liver diseases (author's transl)].
Reis HE; Bertrams J; Kuwert E; Selmair H; Wiese W
Med Klin; 1974 Sep; 69(39):1579-86. PubMed ID: 4456161
[No Abstract] [Full Text] [Related]
8. [Corticosteroid therapy in hepatitis].
Dioguardi N; Pabis A
Clin Ter; 1967 Apr; 41(2):113-31. PubMed ID: 4179415
[No Abstract] [Full Text] [Related]
9. Hepatitis-associated antigen and acute and chronic liver disease in Uganda.
Sadikali F
East Afr Med J; 1972 Oct; 49(10):783-90. PubMed ID: 4666004
[No Abstract] [Full Text] [Related]
10. [Corticosteroid therapy in hepatic diseases].
Mazzacca G
Recenti Prog Med; 1967 Jul; 43(1):51-70. PubMed ID: 4302862
[No Abstract] [Full Text] [Related]
11. [Treatment of patients with chronic hepatitis and cirrhosis of the liver].
Kurdybaĭlo FV; Larina IG; Kulikova AN
Vrach Delo; 1972 Jun; 6():19-23. PubMed ID: 5043595
[No Abstract] [Full Text] [Related]
12. [Immunosuppressive therapy of inflammatory liver diseases].
Meyer zum Büschenfelde ; Perings E; Crettzfeldt W
Ther Umsch; 1971 Sep; 28(9):586-95. PubMed ID: 5122521
[No Abstract] [Full Text] [Related]
13. Controlling chronic liver disease. Part 1.
Rodman MJ
RN; 1976 Jan; 39(1):79-80, 84-5. PubMed ID: 1043138
[No Abstract] [Full Text] [Related]
14. [Clinical evaluation of Australia-antigen detection (author's transl)].
Weise W; Schlicht L; Martin W
Med Klin; 1975 Oct; 70(40):1598-1601. PubMed ID: 1186571
[TBL] [Abstract][Full Text] [Related]
15. [Corticoid therapy in liver diseases].
Runcan V; Buligescu L
Med Interna (Bucur); 1970 Mar; 22(3):259-64. PubMed ID: 5444364
[No Abstract] [Full Text] [Related]
16. [The significance of Australia antigen (HAA) determination for the clinical picture of hepatitis].
Reinhardt M; Schmitz J; Jorke D
Dtsch Z Verdau Stoffwechselkr; 1973; 33(2):57-78. PubMed ID: 4596686
[No Abstract] [Full Text] [Related]
17. [Long-term treatment of chronic aggressive hepatitis and liver cirrhosis using immunosuppressive agents].
Bannaski H
Med Welt; 1974 Sep; 25(39):1551-5. PubMed ID: 4427553
[No Abstract] [Full Text] [Related]
18. [Immunoprevention and immunosuppression of chronic inflammatory liver diseases].
Scheiffarth F
Med Welt; 1974 Oct; 25(40):1589-92. PubMed ID: 4444495
[No Abstract] [Full Text] [Related]
19. Chronic active liver disease reexamined: prognosis hopeful.
Summerskill WH
Gastroenterology; 1974 Mar; 66(3):450-64. PubMed ID: 4591728
[No Abstract] [Full Text] [Related]
20. [Immunological study of Australia antigen in the tissue].
Tsuji T
Nihon Rinsho; 1972 May; 30(5):1139-46. PubMed ID: 4261566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
